Market Overview:
The global fibrosarcoma treatment market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to factors such as increasing incidence of cancer, rising awareness about fibrosarcoma and its treatment options, and technological advancements in the field of cancer treatment. Based on type, the global fibrosarcoma treatment market is segmented into chemotherapy, radiation therapy, surgery, and others. Chemotherapy is further sub-segmented into alkylating agents, antimetabolites,, anthracyclines,, taxanes,. Radiation therapy is further sub-segmented into external beam radiation therapy (EBRT), brachytherapy,. Surgery is further sub-segmented into wide local excision (WLE), limb sparing surgery (LSS), amputation,. Others include targeted therapy and immunotherapy. Based on application, the global fibrosarcoma treatment market is segmented into hospitals,, clinics,, specialized cancer treatment centers,, others). Hospitals are expected to account for the largest share of the global Fibrosarcoma Treatment Market in 2018 owing to increasing number of patients with cancer seeking hospitalization for their care., Clinics are also expected to witness significant growth during the forecast period due to rising demand for outpatient services., Specialized Cancer Treatment Centers are growing rapidly across regions due To better diagnosis rates And improved outcomes associated with these centers.
Product Definition:
Treatment of a fibrosarcoma is based on the size and location of the tumor, as well as your overall health. Treatment may include surgery, radiation therapy, or chemotherapy.
Chemotherapy:
Chemotherapy is a group of medical treatments used to treat cancer. Chemotherapies are drugs and/or radiation therapy used to control or reduce the growth of cancer. The two major categories of chemotherapies include drug therapies and radiation therapies.
Radiation Therapy:
Radiation therapy is a form of treatment that uses high energy waves to destroy cancer cells. Radiation oncology is used in the treatment and diagnosis of various cancers such as skin, breast, lung, colon/rectal, prostate and head & neck. The most common types of cancer treated with radiation are skin (meningioma), brain (malignant glioma), lung (non-small cell lung cancer) and breast (lobular carcinomatosis).
Application Insights:
The others segment held the largest share of the global fibrosarcoma treatment market in 2017. This segment includes extracorporeal shock wave therapy and brachytherapy. Extracorporeal shock wave therapy is used for treating very aggressive forms of cancer that have spread to various organs in the body. It has been approved by U.S FDA for use as a second line treatment option for patients with metastatic breast carcinoma and locally advanced or recurrring non-metastatic breast carcinoma, after initial chemotherapeutic failure or intolerance has been observed with conventional chemotherapy drugs/interventions.
Brachytherapy is used to treat very aggressive forms of cancer that have not responded well to other treatments such as chemotherapy.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of key players, availability of advanced treatments, high patient awareness levels coupled with relatively higher healthcare expenditure levels in this region as compared to other regions. In addition, favorable government initiatives and policies are also expected to drive growth during the forecast period. For instance, National Fibrosarcoma Foundation (NFSF) was established by NAFI is an organization that provides education and support for patients suffering from sarcomas & fibrosarcomas so that they may receive quality care & treatment options while facing these challenges head on together.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to increasing number of cancer cases due lack of physical activity which increases risk factors such as obesity.
Growth Factors:
- Increasing incidence of fibrosarcoma
- Growing awareness about fibrosarcoma and its treatment options
- Rising demand for better and more effective treatments for fibrosarcoma
- Availability of government funding for research on fibrosarcoma treatment
- Technological advancements in the field of cancer treatment
Scope Of The Report
Report Attributes
Report Details
Report Title
Fibrosarcoma Treatment Market Research Report
By Type
Chemotherapy, Radiation Therapy, Surgery, Others
By Application
Hospitals, Clinics, Specialized Cancer Treatment Centers, Others
By Companies
Pfizer, Novartis, Johnson & Johnson, Bristol-Myers Squibb, Eli Lilly, Baxter International, Sun Pharmaceutical, Cadila Pharmaceuticals, Celon Laboratories, Dr. Reddy's Laboratories
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
244
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Fibrosarcoma Treatment Market Report Segments:
The global Fibrosarcoma Treatment market is segmented on the basis of:
Types
Chemotherapy, Radiation Therapy, Surgery, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Specialized Cancer Treatment Centers, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pfizer
- Novartis
- Johnson & Johnson
- Bristol-Myers Squibb
- Eli Lilly
- Baxter International
- Sun Pharmaceutical
- Cadila Pharmaceuticals
- Celon Laboratories
- Dr. Reddy's Laboratories
Highlights of The Fibrosarcoma Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Chemotherapy
- Radiation Therapy
- Surgery
- Others
- By Application:
- Hospitals
- Clinics
- Specialized Cancer Treatment Centers
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Fibrosarcoma Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Fibrosarcoma is a cancerous tumor that arises from the connective tissue in the body. Treatment typically includes surgery to remove the tumor and chemotherapy or radiation therapy to kill any remaining cancer cells.
Some of the major players in the fibrosarcoma treatment market are Pfizer, Novartis, Johnson & Johnson, Bristol-Myers Squibb, Eli Lilly, Baxter International, Sun Pharmaceutical, Cadila Pharmaceuticals, Celon Laboratories, Dr. Reddy's Laboratories.
The fibrosarcoma treatment market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Fibrosarcoma Treatment Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Fibrosarcoma Treatment Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Fibrosarcoma Treatment Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Fibrosarcoma Treatment Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Fibrosarcoma Treatment Market Size & Forecast, 2020-2028 4.5.1 Fibrosarcoma Treatment Market Size and Y-o-Y Growth 4.5.2 Fibrosarcoma Treatment Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Chemotherapy
5.2.2 Radiation Therapy
5.2.3 Surgery
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Specialized Cancer Treatment Centers
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Fibrosarcoma Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Fibrosarcoma Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Chemotherapy
9.6.2 Radiation Therapy
9.6.3 Surgery
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Specialized Cancer Treatment Centers
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Chemotherapy
10.6.2 Radiation Therapy
10.6.3 Surgery
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Specialized Cancer Treatment Centers
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Chemotherapy
11.6.2 Radiation Therapy
11.6.3 Surgery
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Specialized Cancer Treatment Centers
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Chemotherapy
12.6.2 Radiation Therapy
12.6.3 Surgery
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Specialized Cancer Treatment Centers
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Chemotherapy
13.6.2 Radiation Therapy
13.6.3 Surgery
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Specialized Cancer Treatment Centers
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Fibrosarcoma Treatment Market: Competitive Dashboard
14.2 Global Fibrosarcoma Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Pfizer
14.3.2 Novartis
14.3.3 Johnson & Johnson
14.3.4 Bristol-Myers Squibb
14.3.5 Eli Lilly
14.3.6 Baxter International
14.3.7 Sun Pharmaceutical
14.3.8 Cadila Pharmaceuticals
14.3.9 Celon Laboratories
14.3.10 Dr. Reddy's Laboratories